Terapia prin Chelare IP6 Inositol Hexafosfat Anticancer
Terapia prin Chelare
cu IP6, EGCG, Chlorella, Garlic, MSM, NAC, Acid Alfa lipoic
Terapia anticancer cu IP6, EGCG, NAC, Quercitina
1 Terapia prin chelare cu importanta terapeutica de chelare a fierului: Inhibarea
absorbtiei de Fier
prelungeste viata - Longevitate ( prolongs the life span)
2. Terapia prin chelare: Longevitatea in relatia la supraincarcarea cu aluminiu,
mai putin aluminiu
mai Longevivi
3 Terapia prin chelare: IP 6 un agent chelator cu cation bivalent incarcat electric
pozitiv cu afinitate de atragere a uraniului
4 Terapia prin chelare: IP6 Inositol Hexafosfat acidul fitic un produs natural cu efect neuroprotector
ca agent chelator la supraincarcarea cu fier in boala Parkinson
Supraincarcarea cu fier vazut la microscop
| Creier cu depuneri de
fier |
Creier fara depuneri
de fier |
 |
 |
5 Terapia prin chelare: Toxicitatea de citokine la precursori
de oligodendrocite este mediata de fier in patogeneza neurodegenerativa la
Alzheimer,
Parkinson
si Multipla
Scleroza
Chelare din lb. gr. chele care inseamna cleste adica atrage
metalele grele prin polarizare, le elimina prin rinichi
6 Terapia prin chelare: IP6 Inositol Hexafosfat cu actiune de chelare a metalelor
grele ca mercur, plumb, cadmiu, fier, cupru si depunerile de calciu la ateroscleroza
Procesul de ateroscleroza cu leziunile de aterom si scleroza |
 |
- Ateromul se formeaza datorita leziunilor din lipsa cronica de Vitamina C peretii vasculari primesc leziuni iar efectele de reparatie a organizmului compenseaza
necontrolat cresterea cu celule musculare si depunerilor cu Lipoproteina(a)
=
apoa in placa aterosclerotica.
- Liproproteina(apoa) are efect de lipire (Adeziune) de peretii vasculari, a
moleculei LDL (Low Density Lipoprotein), ingrosarea peretelui arterial cu depuneri
de calciu si molecule de Zahar (glucoza).
- Stenoza este ingustarea lumenului arterial pot surveni prin fisurarea
ingrosarii, cu depuneri de trombi (cheaguri de singe) vasele de singe se astupa
cu intreruperea fluxului sanguin prin formarea de cheaguri de singe (tromboza).
- Prezenta aterosclerozei se observa la efort cind nevoia de oxigen
musculaturii este mai mare iar fluxul de singe scazut, care este solutionarea,
vasodilatori L-Arginina, fluiditatea singelui Ulei de Peste, Vitamina E, sau terapia prin chelare a calciului, fierului sau metale grele, apoi mentinerea
unui status de sanatate Anti-Aging - Longevitate.
7. Aspectul toxic al aluminiului
8. Aluminiu implicat la cauza (etiologia) bolii Alzheimer, dementa Parkinsoniana,
scleroza
amiotrofica laterala, insuficienta renala cronica, osteodistrofia
9. Supraincarcarea cu aluminiu in cerebral cu rol activ evident la boala Alzheimer
10. Evidenta teoriei de incrucisare (crosslinking) - Supraincarcarea cu aluminiu
induce reactii de incrucisare
11. Nivelul de Aluminiu in apa si hrana prin ustensiliile de bucatarie
folosite in prepararea hranei sau contaminarea hranei prin containere sau folii
de aluminiu
la impachetare
12. Preventia si tratamentul terapiei de chelare la supraincarcarea cu Aluminiu
13. N-Acetilcisteina, MSM (Metilsulfonilmetan) un antidot la
tratamentul de intoxicatie
cu Aluminiu
14 Terapia prin chelare: Chlorella formeaza cu Leurda (Allium Ursinum) si Usturoi
(Allium Sativum) Garlic un complex (Grupa sulfhidril), care leaga toxinele
(metalele grele, amalgam
dentar) si le elimina prin rinichi.
15 Terapia prin chelare: Chlorella si Garlic cu actiune de chelare a metalelor grele decongestioneaza organismul de toxine, metale grele (Mercur, amalgam dentar)
16 Importanta terapiei prin chelare: a fierului: Ceai Verde un produs natural multifunctional
ca agent chelator la supraincarcarea cu fier si antioxidant cu activitate de
redecere a radicalilor liberi
17 Terapia prin chelare: EGCG
din Ceai Verde reduce nivelul capacitatii totale de legare a fier-ului (CTLF)
si radicalii liberi la supraincarcarea cu fier
18 Ceai
Verde cu Catechine EGCG contine radicalul galoil cu abilitate de inhibare a
activitatii colagenazei in fluidul gingival crevicular la parodontita
19. Ceai Verde un produs natural pentru ingrijirea pielii, reda tonusul si elasticitatea
pierduta prin inhibarea de colagenaza - Anti Aging Skin Care ®
20. Ceai Verde EGCG inhiba interleukin beta induce stimularea de colagenaza la
tendon
21. Ceai Verde EGCG inhiba colagenaza la celulele de cancer de plamin
22 EGCG
din Ceai Verde cu potential terapeutic in fibroza hepatica prin activitatea
de inhibare a colagenazei in celulele hepatice stelate
23. Quercetina cu actiune de chelare si antioxidanta
in peroxidarea lipidica
24. Quercetina agent chelator cu protectie antioxidanta la membrana eritrocitelor si relatia
de chelare a fierului
25. Importanta terapeutica de chelarea fierului: Toxicitatea de citokine
la precursori de oligodendrocite este mediata de fier in patogeneza neurodegenerativa
a bolilor Alzheimer, Parkinson si Scleroza Multipla
26. IP6 Inositol Hexafosfat este un puternic agent chelator pentru preventia
calcificarii in fluidele biologice, necesar in litiaza renala
27. Acidul fitic cu actiune de inhibare de calculi renali calculilor (pietre
la
rinichi), calcificarea progresiva care duce la formarea de pietre
29. IP6 si Inositol ofera protectie impotriva cancerului
30. IP6 Inositol Hexafosfat si
Inositol inhiba cancerul de la laborator in clinica
31. IP6 Inositol Hexafosfat cu acid fitic un citostatic neuronal in hipocampus
32. IP6 Inositol Hexafosfat un produs natural cu efect anti proliferativ la
cancerul mamar in sinergie cu andriamicina si tamoxifen
33. IP6 Inositol Hexafosfat noul anti-cancer cu functie de inhibare a celulelor
de cancer mamar
34. IP6 Inositol Hexafosfat cu efect in hematopoieza cu formarea de celule sangvine
la leucemie
35. IP6 Inositol Hexafosfat cu activitate de anti angiogeneza
36. IP6 Inositol Hexafosfat induce cresterea celulelor killer, corelat cu gena
supresor
tumorala.
39. Acidul fitic cu protectie de dauna oxidativa ADN cu referinte la preventia
citostatica la cancer
40. IP6 Inositol Hexafosfat dependent de doza inhiba cancerul intestinal
41. IP6 Inositol Hexafosfat cu actiune de anti neoplasm inhiba celulele de cancer
42. IP6 Inositol Hexafosfat un anti neoplasm, scade profilul lipidic
43. Acidul Fitic - IP6 Inositol Hexafosfat noul optimizator un anti neoplasm,
reviu
sistematic
44. IP6 Inositol Hexafosfat cu actiune hipolipidica previne grasimea la nivel
hepatic
45. Acidul Fitic un protector al colonului in peroxidarea lipidica.
46. Acidul Fitic cu efect la nivelul de glucoza sanguina si al unelor enzime
pentru carbohidrati si metabolismul lipidic
47. IP6 Inositol Hexafosfat cu: Fenomen UP (up regulation) reduce stimularea
receptorului genei supresor tumorala p53 si expresia genica WAF1 la carcinomul
de colon HT-29.
49. IP6 Inositol Hexafosfat creste activitatea naturala de celulele NK, corelat
cu
inhiba geneza canceroasa
50. IP6 Inositol Hexafosfat in tratamentul de cacer hepatic. IP6 inhiba cresterea
tumorala si transforma fenotipul la linia canceroasa hepatica HepG2.
51. IP6 Inositol Hexafosfat in tratamentul de cancer la ficat, reversia
fenotipul malign la linia canceroasa hepatica HepG2.
52. IP6 Inositol Hexafosfat in tratamentul de cancer 2 la ficat, injectia intra
tumorala cu IP6 cu regres la cancer de ficat
53. IP6 Inositol Hexafosfat si Ceai Verde EGCG la cancerul de pancreas
54. IP6 Inositol Hexafosfat noul optimizator anti-cancer la cancerul
de pancreas
55. IP6 Inositol Hexafosfat induce exocitoza,
cresterea productiei celulelor beta din pancreas
56. IP6 Inositol Hexafosfat cu efect anti-proliferativ la melanomul malign
57. IP6 Inositol Hexafosfat un supresor la cancerul de prostata
58. IP6 Inositol Hexafosfat un anti-tumoral induce apoptoza celulara la carcinomul
de prostata
59. IP6 Inositol Hexafosfat eficacitate si mecanism de actiune
60. IP6 Inositol Hexafosfat cu efect anti plachetar
Bibliografie-Referinte: Terapia prin Chelare
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1. Massie HR, Aiello VR, Williams TR. Inhibition of iron absorption prolongs
the life span of Drosophila. Masonic Medical Research Laboratory, Utica, New
York 13501. Mech Ageing Dev. 1993 Apr;67(3):227-37.
2. Bjorkstein J, Yaeger LL, Wallace T. Control of aluminium ingestion and its
relation to longevity. Bjorksten Research Foundation. Int J Vitam Nutr Res. 1988;58(4):462-5.
3.
Cebrian D, Tapia A, Real A, Morcillo MA. Inositol hexaphosphate: a potential
chelating agent for uranium.
Radiobiology Laboratory, Radiation Dosimetry Unit, Department of Environment,
CIEMAT, Avda Complutense 22, 28040 Madrid, Spain. Radiat Prot Dosimetry. 2007;127(1-4):477-9.
Epub 2007 Jul 12.
4. Xu Q, Kanthasamy AG, Reddy MB. Neuroprotective effect of the natural iron
chelator, phytic acid in a cell culture model of Parkinson's disease. Department
of Biomedical
Sciences, Iowa State University, Ames, IA, United States. Toxicology. 2008
Mar 12;245(1-2):101-8. Epub 2007 Dec 27.
5. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N,
Connor JR. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
Department
of Neurosurgery, Pennsylvania State University, College of Medicine Hershey,
PA 17033, USA. Glia. 2005 Nov 15;52(3):199-208.
6. IP6 attaches to heavy metals such as mercury, lead and cadmium, as well as
loose
iron, copper and calcium. J Agriculture Food Chemistry 47: 4714-17, 999
- Phytic acid: new doors open for a chelator. Lancet. 1987 Sep 19;2(8560):664-6.
7. Hewitt CD, Savory J, Wills MR. Aspects of aluminum toxicity. University of
Virginia Health Sciences Center, Charlottesville. Clin Lab Med. 1990 Jun;10(2):403-22.
8. Wills MR, Savory J. Aluminum and chronic renal failure: sources, absorption,
transport, and toxicity. Department of Pathology and Internal Medicine, University
of Virginia Health Sciences Center, Charlottesville. Crit Rev Clin Lab Sci. 1989;27(1):59-107.
9
McLachlan DR, Lukiw WJ, Kruck TP. New evidence
for an active role of aluminum in Alzheimer's disease. Department of Physiology,
University of Toronto, Ontario,
Canada. Can J Neurol Sci. 1989 Nov;16(4 Suppl):490-7.
- Miu AC, Benga O. Aluminum and Alzheimer's disease: a new look. Program of
Cognitive Neuroscience, Department of Psychology, Babeş-Bolyai University,
Cluj-Napoca,
CJ, Romania. J Alzheimers Dis. 2006 Nov;10(2-3):179-201.
10. Bjorksten J, Tenhu H. The crosslinking theory of aging--added evidence. Bjorksten
Research Foundation, Madison, Wisconsin. Exp Gerontol. 1990;25(2):91-5.
11. Gramiccioni L, Ingrao
G, Milana MR, Santaroni P, Tomassi G. Aluminium levels in Italian diets and in
selected foods from aluminium utensils. Istituto
Superiore di Sanità, Roma, Italy. Food Addit Contam. 1996 Oct;13(7):767-74.
- Pennington JA. Aluminium content of foods and diets. Center for Food Safety
and Applied Nutrition, Food and Drug Administration, Washington, DC. Food Addit
Contam. 1988 Apr-Jun;5(2):161-232
12. Yokel RA, Ackrill P, Burgess E, Day JP, Domingo
JL, Flaten TP, Savory J. Prevention and treatment of aluminum toxicity including
chelation therapy:
status and research needs. College of Pharmacy, University of Kentucky Medical
Center, Lexington 40536-0082, USA. J Toxicol Environ Health. 1996 Aug 30;48(6):667-83.
13. Domingo JL, Llobet JM, Gómez M, Corbella J. Acute aluminium intoxication:
a study of the efficacy of several antidotal treatments in mice. Res Commun
Chem Pathol Pharmacol. 1986 Jul;53(1):93-104
14. Jensen, J. and A. Jernelov. 1969. Biological Methylation of Mercury in
Aquatic Organisms. Nature 223: 753-754.,University of Victoria: Q1 N2.
- Landner L. Biochemical model for the biological methylation of mercury suggested
from methylation studies in vivo with Neurospora crassa.Nature. 1971 Apr 16;230(5294):452-4.
- Shieh Y.; Barger, J.: Uptake of mercury by Chlorella and its effect on potassium
regulation. Planta, 109: 49-60, 1973.
15. Sneddon, J.; Pappas, C.P.: Binding and removal of metal ions in solution
by
an algal biomass. Am.
Environ. Lab, #10 9-13, 1991.
- Aksu, Z; Kutsal, T.: The usage of Chlorella vulgaris in waste water treatment
containing heavy metal ions. Proc. 4th Eur. Cong. Biotech, 2, 80-8 3, 1987.
16. Srichairatanakool
S, Ounjaijean S, Thephinlap C, Khansuwan U, Phisalpong C, Fucharoen S. Iron-chelating
and free-radical scavenging activities of microwave-processed green tea in iron
overload. Department of Biochemistry, Faculty of Medicine, Chiang Mai University,
Thailand. Hemoglobin. 2006;30(2):311-27.
17. Thephinlap
C, Ounjaijean S, Khansuwan U, Fucharoen S, Porter JB, Srichairatanakool S. Epigallocatechin-3-gallate
and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound
iron and erythrocyte oxidative stress.Department of Biochemistry, Faculty of
Medicine, Chiang Mai University, Chiang Mai 50200,
Thailand. Med Chem. 2007 May;3(3):289-96.
18. Makimura
M, Hirasawa M, Kobayashi K, Indo J, Sakanaka S, Taguchi T, Otake S. Inhibitory
effect of tea catechins on collagenase activity. Nihon University School of Dentistry
at Matsudo, Department of Clinical Pathology, Japan. J Periodontol.
1993 Jul;64(7):630-6.
19. Madhan
B, Krishnamoorthy G, Rao JR, Nair BU. Role of green tea polyphenols in the inhibition
of collagenolytic activity by collagenase. Central Leather
Research
Institute, Adyar, Chennai 600020, India. Int J Biol Macromol. 2007 Jun 1;41(1):16-22.
Epub 2006 Dec 12.
20. Corps AN, Curry VA, Buttle DJ, Hazleman BL, Riley GP. Inhibition of interleukin-1beta-stimulated
collagenase and stromelysin expression in human tendon fibroblasts by epigallocatechin
gallate ester. Rheumatology Research Unit, Box 194, Addenbrooke's Hospital, Hills
Road, Cambridge CB2 2QQ, UK. Matrix Biol. 2004 Jun;23(3):163-9.
21. Author: Sazuka, M : Imazawa, H : Shoji, Y : Mita, T : Hara, Y : Isemura,
M Inhibition of collagenases from mouse lung carcinoma cells by green tea catechins
and black tea theaflavins. Citation: Biosci-Biotechnol-Biochem. 1997 Sep; 61(9):
1504-6
22. Nakamuta
M, Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Kobayashi N, Enjoji
M. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses
both
collagen production and collagenase activity in hepatic stellate cells. Department
of Medicine and Bioregulatory Science, Graduate School of Medical Sciences,
Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Int
J Mol Med.
2005 Oct;16(4):677-81.
23. Afanas'ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI.
Chelating and free radical scavenging mechanisms of inhibitory action of rutin
and quercetin in lipid peroxidation. All-Union Vitamin Research Institute,
Moscow, U.S.S.R. Biochem Pharmacol. 1989 Jun 1;38(11):1763-9.
24. Ferrali M, Signorini C, Caciotti B, Sugherini L, Ciccoli L, Giachetti D,
Comporti M. Protection against oxidative damage of erythrocyte membrane by the
flavonoid quercetin and its relation to iron chelating activity. Institute of
General
Pathology, University of Siena, Italy. FEBS Lett. 1997 Oct 20;416(2):123-9.
25. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N,
Connor JR. Cytokine toxicity to oligodendrocyte precursors is mediated by iron.
Department of Neurosurgery, Pennsylvania State University, College of Medicine
Hershey,
PA 17033, USA. Glia. 2005 Nov 15;52(3):199-208.
26. Grases F, Costa-Bauzá A. Phytate
(IP6) is a powerful agent for preventing calcifications in biological fluids:
usefulness in renal
lithiasis treatment.
Laboratory of
Investigation into Renal Lithiasis, Faculty of Sciences, University of
Illes Balears, Palma
de Mallorca, Spain. Anticancer Res. 1999 Sep-Oct;19(5A):3717-22.
27. Grases F,
Isern B, Sanchis P, Perello J, Torres JJ, Costa-Bauza A. Phytate acts as
an inhibitor in formation of renal calculi. Laboratory of Renal Lithiasis
Research, University Institute of Health Sciences Research (IUNICS),
University of Balearic Islands, Palma of Mallorca, Spain. Front Biosci. 2007
Jan 1;12:2580-7.
28. Shamsuddin AM, Vucenik I, Cole KE. (1997), "IP6:
A novel anti-cancer agent."; Life Sci 61(4): 343-54.
29. Vucenik I, Shamsuddin AM. Protection against cancer by dietary IP6
and inositol. Nutr Cancer 2006:55(2):109-25.
30. Vucenik I, Shamsuddin AM. Protection against
cancer by dietary IP6 and inositol. Nutr Cancer 2006:55(2):109-25. Vucenik
I, Shamsuddin AM. Cancer inhibition by
inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.
Department of Medical and Research
Technology,
University of Maryland School of Medicine, Baltimore, MD 21201, USA.
J Nutr. 2003 Nov;133(11 Suppl
1):3778S-3784S.
31. Lees GJ, Leong W. Neuronal cytotoxicity of inositol hexakisphosphate
(phytate) in the rat hippocampus. Department of Psychiatry and Behavioural
Science,
School of Medicine, University of Auckland, New Zealand. Brain Res. 1996
Nov 25;741(1-2):134-41.
32. Tantivejkul K, Vucenik I, Eiseman J, Shamsuddin AM. Inositol hexaphosphate
(IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen
in breast cancer. Department of Pathology, University of Maryland School
of Medicine,
Baltimore, MD 21201, USA. Breast Cancer Res Treat. 2003 Jun;79(3):301-12.
33. Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer functions of IP6:
growth inhibition and differentiation of human mammary cancer cell lines
in vitro.Department
of Pathology, University of Maryland School of Medicine, Baltimore 21201-1192,
USA. Anticancer Res. 1996 Nov-Dec;16(6A):3287-92.
34. Deliliers GL, Servida F, Fracchiolla NS, Ricci C, Borsotti C, Colombo
G, Soligo D. Effect of inositol hexaphosphate (IP(6)) on human normal and
leukaemic
haematopoietic
cells. Bone Marrow Transplantation Unit, I.R.C.C.S., Ospedale Maggiore
and University of Milan, Via F. Sforza 35, 20122 Milan, Italy. Br J Haematol.
2002 Jun;117(3):577-87.
35. Vucenik I, Passaniti A, Vitolo MI, Tantivejkul K, Eggleton P, Shamsuddin
AM. Anti-angiogenic activity of inositol hexaphosphate (IP6). Department
of Medical and Research Technology, University of Maryland School of Medicine,
Baltimore, MD, USA. Carcinogenesis. 2004 Nov;25(11):2115-23. Epub 2004
Aug 5.
36. Baten A, Nabi ZF, Zucker-Franklin D. (1989), "Inositol-phosphate-induced
enhancement of natural killer cell activity correlates with tumor suppression.";Carcinogenesis
10(9): 1595-8.
37. Vucenik I, Kalebic T, Tantivejkul K, Shamsuddin AM. Novel anticancer
function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma
in vitro and
in vivo. Department of Medical and Research Technology, University of Maryland
School of Medicine, Baltimore 21201, USA. Anticancer Res. 1998 May-Jun;18(3A):1377-84.
38. Graf E, Empson KL, Eaton JW. Phytic acid. A natural antioxidant. J
Biol Chem. 1987 Aug 25;262(24):11647-50.
39. Midorikawa K, Murata M, Oikawa S, Hiraku Y, Kawanishi S. Protective
effect of phytic acid on oxidative DNA damage with reference to cancer
chemoprevention.
Department of Hygiene, Mie University School of Medicine, Mie, 514-8507,
Japan. Biochem
Biophys Res Commun. 2001 Nov 2;288(3):552-7.
40. Ullah A, Shamsuddin AM. Dose-dependent inhibition of large intestinal
cancer by inositol hexaphosphate in F344 rats. Department of Pathology, University
of Maryland, School of Medicine, Baltimore 21201. Carcinogenesis. 1990 Dec;11(12):2219-22.
41. El-Sherbiny YM, Cox MC, Ismail ZA, Shamsuddin AM, Vucenik I. G0/G1 arrest
and S phase inhibition of human cancer cell lines by inositol hexaphosphate
(IP6). Department of Clinical Pathology University of Minia School of Medicine,
Egypt.
Anticancer Res. 2001 Jul-Aug;21(4A):2393-403.
42. Jariwalla RJ. Inositol hexaphosphate
(IP6) as an anti-neoplastic and lipid-lowering agent. Anticancer Res. 1999;19:3699-3702.
43. Fox CH, Eberl M. Phytic acid (IP6), novel broad spectrum anti-neoplastic
agent: a systematic review. Complement Ther Med 2002;10(4):229-34.
44. Katayama T. Hypolipidemic action of phytic acid (IP6): prevention
of fatty liver. Laboratory of Nutritional Science, Faculty of Education,
Hiroshima University,
Japan. Anticancer Res. 1999 Sep-Oct;19(5A):3695-8.
45. Porres JM, Stahl CH,
Cheng WH, Fu Y, Roneker KR, Pond WG, Lei XG. (1999), Dietary
intrinsic phytate protects colon from lipid peroxidation in pigs with a
moderately high dietary iron intake.
Proc Soc Exp Biol Med 221(1): 80-6.
46. Dilworth LL, Omoruyi FO, Simon OR, Morrison EY, Asemota HN. The effect
of phytic acid on the levels of blood glucose and some enzymes of carbohydrate
and
lipid
metabolism. Department of Basic Medical Sciences, The University of the
West Indies, Kingston 7, Jamaica, West Indies. West Indian Med J. 2005 Mar;54(2):102-6.
47. Saied IT, Shamsuddin AM. (1998), "Up-regulation
of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29
human colon carcinoma cell line.";
Anticancer Res 18(3A): 1479-84.
48. Challa A, Rao DR, Reddy BS.(1997), "Interactive
suppression of aberrant crypt foci induced by azoxymethane in rat colon by
phytic acid and green tea."; CArcinogenesis 18(10): 2023-6.
49. Zhang Z, Song Y, Wang XL. Inositol hexaphosphate-induced enhancement
of natural killer cell activity correlates with suppression of colon carcinogenesis
in
rats. Department of Biochemistry and Molecular Biology, Qingdao University
Medical College, Qingdao 266021, Shandong Province, China. World J Gastroenterol.
2005 Aug 28;11(32):5044-6.
50. Vucenik I, Zhang ZS, Shamsuddin AM. (1998), "IP6
in treatment of liver cancer. IP6 inhibits growth and reverses transformed
phenotype in HepG2 human liver cancer cell line.";
Anticancer Res 18(6A): 4083-90.
51. Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM.
IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed
phenotype in HepG2 human liver cancer cell line. Department of Medical
and Research Technology, University of Maryland School of Medicine, Baltimore
21201,
USA.
Anticancer Res. 1998 Nov-Dec;18(6A):4083-90.
52. Vucenik I, Zhang ZS, Shamsuddin AM. IP6 in treatment of liver cancer.
II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer
xenotransplanted
in nude mice. Department of Medical and Research Technology, University
of Maryland School of Medicine, Baltimore 21201, USA. Anticancer Res. 1998
Nov-Dec;18(6A):4091-6.
53. McMillan B, Riggs DR, Jackson BJ, Cunningham C, McFadden DW. Dietary
influence on pancreatic cancer growth by catechin and inositol hexaphosphate.
Department
Of Surgery, Robert C. Byrd Health Science Center, West Virginia University,
Morgantown, West Virginia, USA. J Surg Res. 2007 Jul;141(1):115-9.
54. Somasundar P, Riggs DR, Jackson BJ, Cunningham C, Vona-Davis L, McFadden
DW. Inositol hexaphosphate (IP6): a novel treatment for pancreatic cancer.
Louis A. Johnson VA Medical Center, Clarksburg, West Virginia; Department
of Surgery, West Virginia University, Morgantown, West Virginia, USA. J
Surg Res.
2005 Jun 15;126(2):199-203.
55. Høy M, Berggren PO, Gromada J. Involvement
of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis
in mouse pancreatic
beta-cells. Laboratory of Islet Cell Physiology, Novo Nordisk A/S, Novo
Alle,
DK-2880 Bagsvaerd, Denmark. J Biol Chem. 2003 Sep 12;278(37):35168-71.
Epub 2003 Jul 1.
56. Rizvi I, Riggs DR, Jackson BJ, Ng A, Cunningham C, McFadden DW.
Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma.
Department of Surgery, Robert C. Byrd Health Science Center, West Virginia
University,
Morgantown,
West Virginia 26506, USA. J Surg Res. 2006 Jun 1;133(1):3-6. Epub 2006
Mar 23.
57. Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C,
Agarwal R. In vivo suppression of hormone-refractory prostate cancer
growth by inositol
hexaphosphate: induction of insulin-like growth factor binding protein-3
and inhibition of vascular endothelial growth factor. Department of Pharmaceutical
Sciences, University of Colorado Cancer Center, University of Colorado
Health Sciences Center, Denver, Colorado, USA. Clin Cancer Res. 2004
Jan 1;10(1
Pt 1):244-50.
- Diallo JS, Betton B, Parent N, Péant
B, Lessard L, Le Page C, Bertrand R, Mes-Masson AM, Saad F. Enhanced
killing of androgen-independent prostate cancer cells using inositol hexakisphosphate
in combination with proteasome inhibitors. Centre de Recherche du Centre
Hospitalier
de l'Université de Montréal (CR-CHUM) and Institut du Cancer de Montréal, Montréal, Québec, Canada. Br J Cancer. 2008 Nov 18;99(10):1613-22. Epub 2008 Oct 21.
58. Singh RP, Agarwal C, Agarwal R. Inositol hexaphosphate inhibits growth,
and induces G1 arrest and apoptotic death of prostate carcinoma DU145
cells: modulation
of CDKI-CDK-cyclin and pRb-related protein-E2F complexes. Department
of Pharmaceutical Sciences, School of Pharmacy and University of Colorado Cancer
Center, University
of Colorado Health Sciences Center, Denver, CO 80262, USA. Carcinogenesis.
2003 Mar;24(3):555-63.
59. Singh RP, Agarwal R. Prostate cancer and inositol hexaphosphate:
efficacy and mechanisms. Department of Pharmaceutical Sciences, School
of Pharmacy,
University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Anticancer Res. 2005
Jul-Aug;25(4):2891-903.
60. Vucenik I, Podczasy JJ, Shamsuddin AM. Antiplatelet activity of inositol
hexaphosphate (IP6). Department of Medical and Research Technology, University
of Maryland School of Medicine Baltimore 21201, USA. Anticancer Res.
1999 Sep-Oct;19(5A):3689-93.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.
|
Terapia prin chelare cu importanta terapeutica de chelare a fierului: Inhibarea absorbtiei de Fier prelungeste viata - Longevitate ( prolongs the life span)
